GGHCX
Price
$38.37
Change
-$0.52 (-1.34%)
Updated
Feb 3 closing price
Net Assets
1.23B
JNGLX
Price
$81.82
Change
+$6.95 (+9.28%)
Updated
Feb 3 closing price
Net Assets
5.36B
Interact to see
Advertisement

GGHCX vs JNGLX

Header iconGGHCX vs JNGLX Comparison
Open Charts GGHCX vs JNGLXBanner chart's image
Invesco Health Care A
Price$38.37
Change-$0.52 (-1.34%)
VolumeN/A
Net Assets1.23B
Janus Henderson Global Life Sciences D
Price$81.82
Change+$6.95 (+9.28%)
VolumeN/A
Net Assets5.36B
GGHCX vs JNGLX Comparison Chart in %
View a ticker or compare two or three
VS
GGHCX vs. JNGLX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGHCX is a StrongBuy and JNGLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 5.36B vs. GGHCX (1.23B). JNGLX pays higher dividends than GGHCX: JNGLX (0.43) vs GGHCX (0.00). GGHCX was incepted earlier than JNGLX: GGHCX (37 years) vs JNGLX (27 years). GGHCX (1.05) is less costly to investors than JNGLX (0.80). GGHCX is a more actively managed with annual turnover of: 59.00 vs. JNGLX (30.00). GGHCX has a lower initial minimum investment than JNGLX: GGHCX (1000) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : 15.11 vs. GGHCX (0.26). JNGLX return over 5 years is better than : 15.42 vs. GGHCX (-16.80).
GGHCXJNGLXGGHCX / JNGLX
Total Expense Ratio1.050.80131%
Annual Report Gross Expense Ratio1.050.80131%
Fund Existence37 years27 years-
Gain YTD-0.9551.025-93%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets1.23B5.36B23%
Annual Yield % from dividends0.000.43-
Returns for 1 year0.2615.112%
Returns for 3 years13.0523.7255%
Returns for 5 years-16.8015.42-109%
Returns for 10 years19.7598.2520%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BW11.151.08
+10.72%
Babcock & Wilcox Enterprises
ENLV1.090.05
+4.81%
Enlivex Therapeutics Ltd
DUK121.672.18
+1.82%
Duke Energy Corp
OBDC11.09-0.40
-3.48%
Blue Owl Capital Corp
LSF2.78-0.26
-8.55%
Laird Superfood